AKR1B10 has been proposed as a promising new diagnostic marker in NSCLC of smokers since it is often overexpressed inmoderate or poorly differentiated NSCLC (in 84% of squamous cell carcinomas and in 29% of adenocarcinomas), mostly in males and smokers [28]. Here, AKR1B10 is linked to squamous cell carcinoma.